Exploring Antimalarial Activity of Chalcone Derivatives through QSAR

Year : 2025 | Volume : 03 | Issue : 02 | Page : –
    By

    Neerja Shukla,

  • Anita Singh,

  • Rahila Khan,

  • Shashikant Verma,

  • Anushka Shukla,

  • Kumari Suman,

  • Bechan Sharma,

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_187319’);});Edit Abstract & Keyword

Background:  The core structure of chalcones contains a reactive α,β-unsaturated system within the aromatic rings, which plays a key role in mediating various biological effects. These effects include enzyme inhibition, anticancer activity, anti-inflammatory properties, as well as antibacterial, antifungal, antimalarial, antiprotozoal, and anti-filarial actions.Modifying the structure by introducing substituent groups to the aromatic ring can enhance potency, reduce toxicity, and expand their range of pharmacological actions.

Methods: A total of twenty-seven chalcone derivatives were analyzed for their physicochemical and molecular properties. Chalcones exhibit a broad spectrum of pharmacological properties, encompassing antibacterial, antifungal, anti-inflammatory, and anticancer activities, making them promising candidates for therapeutic development, and molecular connectivity (χ), were computed using E-Dragon software.The software primarily accepts molecular file formats such as SMILES notations, which were generated online using Babel software. These 2D structures were then converted into 3D optimized structures using CORINA, an online tool provided by Molecular Networks GmbH. Furthermore, the 3D structures of the compounds were constructed using GaussView software to calculate various quantum chemical descriptors based on density functional theory (DFT). The analysis included key values such as total energy, softness, hardness, chemical potential, and the energy levels of the molecule’s outermost electrons — specifically, the highest occupied (HOMO) and lowest unoccupied (LUMO) orbitals. All the compounds were completely optimized in the gas phase using the 6-31+G* basis set for accurate structural calculations. To ensure that the optimized structures represented true energy minima, harmonic vibrational frequency calculations were carried out—confirmed by the presence of only positive vibrational frequencies.

Results: A comprehensive array of molecular descriptors—including D, ID, IOR, Log P, Mr, Mv, Mw, Pc, BAC, Pz, St, W, Wa, 0c, 1c, 2c, 3c, 4c, 5c, and Xeq—has been recognized as crucial for effectively modeling the biological activity of the investigated compounds. These descriptors serve as fundamental parameters in capturing the structural and physicochemical complexities necessary for accurate predictive analysis.

QSAR Model 2, mathematically represented by the following equation:

pIC50 = -20.605 (±6.600) IOR – 0.747 (±0.454) I1 – 5.083 (±3.478) Xeq + 51.647

This model was systematically refined using empirical parameters to enhance its predictive accuracy. Each coefficient in the equation signifies the relative influence of the corresponding molecular descriptor on the predicted biological activity. The negative values associated with IOR, I1, and Xeq indicate an inverse correlation between these descriptors and the pIC50 values, suggesting their role in modulating compound potency. The optimization process involved fine-tuning these parameters to achieve the best fit with the experimental data, ensuring a robust and reliable depiction of the structure-activity relationship.

Conclusions: The QSAR model suggests that substituents with lower refractive indices and less electronegative groups improve activity. In contrast, indomethacin derivatives containing a -CH2CH2NHCONH(CH2)3ONO2 group at the R1 position negatively impact activity.The findings are critically analyzed using regression data and cross-validation techniques. The Poglani factor (Q) and results from the LOO (leave-one-out) method validate the reliability and predictive accuracy of the proposed models, offering valuable insights for designing new analogues with improved potency in the future.

Keywords: Indomethacin Derivatives, Poglani Factor (Q), LOO (Leave-One-Out), Anti-inflammatory Activity, and Potency.

[This article belongs to International Journal of Bioinformatics and Computational Biology ]

How to cite this article:
Neerja Shukla, Anita Singh, Rahila Khan, Shashikant Verma, Anushka Shukla, Kumari Suman, Bechan Sharma. Exploring Antimalarial Activity of Chalcone Derivatives through QSAR. International Journal of Bioinformatics and Computational Biology. 2025; 03(02):-.
How to cite this URL:
Neerja Shukla, Anita Singh, Rahila Khan, Shashikant Verma, Anushka Shukla, Kumari Suman, Bechan Sharma. Exploring Antimalarial Activity of Chalcone Derivatives through QSAR. International Journal of Bioinformatics and Computational Biology. 2025; 03(02):-. Available from: https://journals.stmjournals.com/ijbcb/article=2025/view=0



document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_187319’);});Edit

References

1. Ramos-Inza S., Encio I., Raza A., Sharma A. K., Sanmartin C., Plano D., Design, synthesis and anticancer evaluation of novel Se- NSAID hybrid molecules: Identification of a Se- indomethacin analog as a potential therapeutic for breast cancer., Euro. Jour. Of Med. Chem., 2022, 244, 114-839.
2. Bardia A., Olson J. E., Vachon C. M., Lazovich D., Vierkant R. A., Wang A. H., Limburg P. J., Anderson K. E., Cerhan J. R., Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study., Breast Cancer Res. Treat., 2011, 126,149-155.
3. Perontsis S., Geromichalou E., Perdih F., Hatzidimitriou A. G., Geromichalos G. D., Turel I., Psomas G., Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin., J. Inorg. Biochem., 2020, 212, 111-213.
4. Wang H., Chang Z., Cai G-d., Yang P., Chen J-H., Yang S-S., Guo Y.-F., Wang M.-Y., Zheng X.-H., Lei J.-P., Liu P.-Q., Zhao D.-P., Wang J.-J., The novel Indomethacin derivative CZ-212-3 exerts antitumor effects on castration- resistant prostate cancer by degrading androgen receptor and its variants., Acta. Pharmacol. Sin., 2022, 43(4), 1024-1032.
5. Jain H.K., QSAR analysis of Indomethacin derivatives as selective COX-2 inhibitors., Internet Electronic Journal of Molecular Design., 2006, 5(4), 224-236.
6. Obata T., Shiratani S., Nada T., Kasaya Y., Arisawa M., Shuto S., Tanaka M., Structure-activity Relationship of Indomethacin Derivatives as IDO1 Inhibitors., Anticancer Research, 2021, 41(5), 2287-2296.
7. Sava A., Buron F., Routier S., Panainte A., Bibire N., Constantin S. M., Lupascu F. G., Focsa A. V., Profire L., Design, synthesis, in silico and in vitro studies for new nitric oxide- releasing indomethacin derivatives with 1, 3, 4- oxadiazole- 2- thiol scaffold., Int. J. Mol. Sci., 2021, 22(13), 70-79.
8. Nabil M., El Raey M. A., Abdo W., Abdelfattah M. A. O., El-Shazly A. M., Sobeh M., Mahmoud M. F., Gastro- protective effects of Albizia anthelmintica leaf extract on Indomethacin- induced gastric ulcer in wistar rats: in silico and in vivo studies., Antioxidants., 2021, 10(2), 176.
9. Srivastava A. K., ShuklaN. and Pathak V. K., Quantitative Structure Activity Relationship (QSAR) Studies on a series of off-target ion channel selective diltiazem sodium derivatives., J. Indian Chem. Soc., 2010, 87,1-7.
10. John A. Yagiela, Frank J. Dowd, Bart Johnson, Angelo Mariotti, Enid A. Neidle. Pharmacology and Therapeutics for Dentistry., Chapter 23, Drugs for Treating Orofacial Pain Syndromes. 384-385
11. Srivastava A.K., Shukla N., Pandey A. and Srivastava A., QSAR Based Modeling on a series of alpha-Hydroxy amides as a novel class of Braykinin B1 selective antagonists., J. Saudi Chem. Soc., 15, 2011, 215-220.
12. SrivastavaA.K., Pandey A., Srivastava A.and Shukla N., QSAR based modeling of hepatitis C virus NS5B inhibitors ., J. Saudi Chem. Soc., 15, 2011, 25-28.
13. Srivastava A. K., Shukla N., Quantitative structure activity relationship (QSAR) studies on a series of imidazole derivatives as novel ORL1 receptor antagonists, Journal of Saudi Chemical Society, 2013, 17 (3), 321-328.
14. Sharma D., Shukla S. D., Neuroprotection: It’s Phytoremediation (Theoretical Perspective), International Journal of Green and Herbal Chemistry, 2013,2,1118-1131.
15. Shukla N., Srivastava A. K.QSAR based modeling on a novel series of 2-chlorobenzamide derivatives as potent P2X (7) receptor antagonist, Oxidation Communications, 2014, 37 (1), 290-300.
16. Srivastava A. K., Shukla N., Pathak V. K. Quantitative Structure ActivityRelationship(QSAR) Studies on a series of carbamate appended N-alkylsulfonamides as inhibitors of peptide amyloid- β (Aβ), Oxidation Communications, 2013, 36 (4), 1090-1101.
17. Shukla N., Srivastava A. K., QSAR studies on a novel cyclohexanamine class of human serotonin transporter (hSERT) inhibitory activity, Oxidation Communications, 2013, 36 (1), 133-142.
18. Srivastava A. K., Shukla N., QSAR-based Modelling on a Novel Series of Pyrimidine-4-carboxamides as Antagonists of the Human A1 Receptor,, Oxidation Communications, 35 (2), 423-437.
19. Diudea,M.V.,2000.,QSPR/QSAR StudiesforMolecularDescriptors.NovaScience,Huntington,NewYork.
20. QSAR methods & applications, Gyandhara International Academy Publications, Thane, Mumbai, ISBN No. 978-93-83006-83-0.
21. Sahu R., Yadav P. K., Mishra P., Shukla N., Identification, and characterization of a novel therapeutic drugtarget in Mycobacterium abscessus by in silico method, International Journal of Green and Herbal Chemistry, 2019, 8, 091-107.
22. Neerja Shukla, Shashikant Verma. QSAR modelling of a novel series of methoxylated chalcones as antioxidant agents against Gram-positive bacteria Staphylococcus aureus. International Journal of Biochemistry and Biomolecule Research. 2025, 03 (01)

Regular Issue Subscription Original Research
Volume 03
Issue 02
Received 17/03/2025
Accepted 20/04/2025
Published 03/05/2025
Publication Time 47 Days
Total Visits: 12

[last_name]

My IP

PlumX Metrics